Change of Adviser

24th January 2017 - 6:25 pm

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, is pleased to announce that it has appointed Northland Capital Partners as its Nominated Adviser and sole broker with immediate effect.

Share this article

Leave a comment